STRAGEN NORDIC A/S: Financial statements 2012
CVR: 26717825
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 39,507,656 and a net result of DKK -2,789,164. The profit margin was -7.1%. Equity in the 2012 report amounted to DKK 2,968,455. The solvency ratio was 27.8%.
- Revenue
- DKK 39,507,656
- Gross Profit
- DKK 2,093,540
- Profit/Loss
- DKK -2,789,164
- Equity
- DKK 2,968,455
- Total Assets
- DKK 10,670,842
Official annual report
Keep an eye on STRAGEN NORDIC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of September 4, 2012, KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of STRAGEN NORDIC A/S.
As of May 24, 2012, PIASTER, LØFGREEN & PARTNERE, STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of STRAGEN NORDIC A/S.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.